Invitrogen Corporation (Public, NASDAQ:IVGN) Stratagene Ordered to Shell Out Triple the Amount Previously Awarded in the Invitrogen Lawsuit
In a patent infringement case, a U.S. court awarded Invitrogen $16.2 million in damages. On July 25, 2006, the jury found that Stratagene had willfully infringed on Invitrogen's valid 4,981,797 patent by making and selling its competent E. coli cell products. http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://www.azhttp.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/